Taiho Pharma to roll out Abraxane
Taiho Pharma said that Abraxane features improved efficacy and safety as well as easier administration compared to solvent-based paclitaxel. Originally, Abraxane was developed by Abraxis BioScience as a
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Oracle claimed that Agile PLM 9.3.1 provides deeper product lifecycle analytics, next generation multi-CAD integrations, complex technical documents management, design variant management and other usability and functional enhancements.
The 12-week, randomised, double-blind, multicenter Phase III study demonstrated that Lixisenatide was safe and well tolerated in patients with type 2 diabetes. The trial result suggested that Lixisenatide
Cellectis bioresearch and Helix Biocon aim to promote Cellectis bioresearch’s meganuclease-based products and services in India. Cellectis bioresearch Sales and Marketing VP Luc Selig said that Cellectis bioresearch